GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea · Delayed Price · Currency is KRW 12,950
+30 (0.23%)
At close: Jan 27, 2026
GFC Life Science Revenue
In the year 2021, GFC Life Science had annual revenue of 13.74B KRW with 3.09% growth. GFC Life Science had revenue of 4.18B in the quarter ending September 30, 2025, a decrease of -10.71%.
Revenue
13.74B
Revenue Growth
+3.09%
P/S Ratio
4.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
67.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 13.74B | 412.37M | 3.09% |
| Dec 31, 2020 | 13.32B | 1.42B | 11.89% |
| Dec 31, 2019 | 11.91B | 3.23B | 37.21% |
| Dec 31, 2018 | 8.68B | 1.52B | 21.20% |
| Dec 31, 2017 | 7.16B | 154.44M | 2.20% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TEMC CNS | 174.96B |
| YMT Co., Ltd. | 142.73B |
| Changhae Ethanol | 120.57B |
| TN entertainment | 113.90B |
| Daejung Chemicals & Metals | 104.05B |
| CQV Co., Ltd. | 59.68B |
| Chemtros | 52.11B |
| Samyang KCI | 31.04B |